Bone Biologics Corp (1419554) SEC Filing 8-K Material Event for the period ending Friday, June 28, 2019

SEC Filings

1419554 Corporate News

  • Event for Officers
    Financial Exhibit
    New Agreement

    June 2019

Bone Biologics Corp

CIK: 1823733

View differences made from one to another to evaluate Bone Biologics Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Bone Biologics Corp.


Assess how Bone Biologics Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Bone Biologics Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Bone Biologics Corp provided additional information to their SEC Filing as exhibits

CIK: 1419554
Form Type: 8-K Corporate News
Accession Number: 0001493152-19-009880
Submitted to the SEC: Fri Jun 28 2019 3:13:53 PM EST
Accepted by the SEC: Fri Jun 28 2019
Period: Friday, June 28, 2019
Industry: Orthopedic Prosthetic And Surgical Appliances And Supplies
  1. Event for Officers
  2. Financial Exhibit
  3. New Agreement

External Resources:

Bookmark the Permalink: